Evaluating The Safety And Clinical Efficacy Of Elderberry Extract In Patients With Influenza
Status:
Completed
Trial end date:
2019-06-25
Target enrollment:
Participant gender:
Summary
This research is being done to determine if an extract of cooked elderberries will help
decrease the duration and severity of influenza symptoms in patients with confirmed
influenza. Involvement in this study requires an initial patient screening at the time of
their Emergency Department visit in order to confirm eligibility for the study. Once patients
have been consented and enrolled as a participant, they will be randomized to take by mouth
either Elderberry Extract or a placebo (a similar appearing and tasting liquid without
elderberry) for a duration of 5 days. Study information regarding medication adherence, body
temperature, symptoms, severity of symptoms, and any possible side effects will be collected
from daily phone surveys conducted by the study coordinator. Participation in the study will
end after at least 5 days once the patient has not had a temperature above 100°F and has had
no influenza symptoms for at least 24 hours, or after 21 days in the study, whichever occurs
first.